Group One Trading
NGNE icon

Group One Trading’s Neurogene NGNE Stock Holding History

Group One Trading’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.02K Sell
100
-1,700
-94% -$32.9K ﹤0.01% 7052
2025
Q4 		$37.1K Buy
1,800
+1,700
+1,700% +$42.3K ﹤0.01% 5842
2025
Q3 		$1.73K Hold
100
– – ﹤0.01% 7938
2025
Q2 		$1.5K Sell
100
-900
-90% -$14.1K ﹤0.01% 7488
2025
Q1 		$11.7K Buy
1,000
+900
+900% +$15.6K ﹤0.01% 6155
2024
Q4 		$2.29K Hold
100
– – ﹤0.01% 6698
2024
Q3 		$4.2K Buy
+100
New +$3.88K ﹤0.01% 5942
2022
Q2 		– Sell
-90
Closed -$3K – 8269
2022
Q1 		$3K Buy
90
+30
+50% +$1.75K ﹤0.01% 7636
2021
Q4 		$6K Buy
+60
New +$7.31K ﹤0.01% 7586
2021
Q1 		– Sell
-90
Closed -$25K – 7872
2020
Q4 		$25K Sell
90
-505
-85% -$123K ﹤0.01% 5396
2020
Q3 		$143K Sell
595
-40
-6% -$9.69K ﹤0.01% 3915
2020
Q2 		$211K Buy
635
+535
+535% +$139K ﹤0.01% 3336
2020
Q1 		$23K Buy
+100
New +$20.6K ﹤0.01% 4159
2018
Q4 		– Sell
-1,000
Closed -$59K – 5221
2018
Q3 		$59K Sell
1,000
-3,810
-79% -$225K ﹤0.01% 3876
2018
Q2 		$255K Buy
4,810
+1,760
+58% +$459K ﹤0.01% 2856
2018
Q1 		$859K Buy
3,050
+2,525
+481% +$697K 0.01% 1637
2017
Q4 		$123K Sell
525
-395
-43% -$92.5K ﹤0.01% 3238
2017
Q3 		$261K Buy
920
+520
+130% +$149K ﹤0.01% 2568
2017
Q2 		$113K Sell
400
-1,305
-77% -$373K ﹤0.01% 3036
2017
Q1 		$569K Buy
1,705
+1,700
+34,000% +$597K 0.01% 1766
2016
Q4 		$2K Buy
+5
New +$1.34K ﹤0.01% 4255

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Group One Trading's NGNE Position: Q1 2024 in Review

Group One Trading sold out of Neurogene (NGNE) in Q1 2024, closing a stake of 74 shares — an estimated $1.43K sold.

Group One Trading first reported a position in NGNE in Q3 2016 and held it in 16 quarters. The position peaked at $200K in Q1 2017. 60 funds tracked by Wall St. Rank hold NGNE as of Q1 2024.

  • Group One Trading reported no remaining Neurogene position as of Q1 2024 after selling out during the quarter.
  • Group One Trading sold 74 Neurogene shares in Q1 2024, an estimated $1.43K.
  • Group One Trading first reported a position in Neurogene in Q3 2016 and held it in 16 quarters.
  • Group One Trading's Neurogene position peaked at $200K in Q1 2017.
  • 60 funds tracked by Wall St. Rank held Neurogene as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.